Does DEXLANSOPRAZOLE Cause Nephrolithiasis? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Nephrolithiasis have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.4% of all adverse event reports for DEXLANSOPRAZOLE.
102
Reports of Nephrolithiasis with DEXLANSOPRAZOLE
0.4%
of all DEXLANSOPRAZOLE reports
7
Deaths
24
Hospitalizations
How Dangerous Is Nephrolithiasis From DEXLANSOPRAZOLE?
Of the 102 reports, 7 (6.9%) resulted in death, 24 (23.5%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does DEXLANSOPRAZOLE Cause?
Chronic kidney disease (15,973)
Acute kidney injury (7,599)
Renal failure (6,618)
End stage renal disease (4,800)
Renal injury (4,320)
Tubulointerstitial nephritis (2,177)
Death (1,417)
Rebound acid hypersecretion (1,160)
Gastrooesophageal reflux disease (1,013)
Drug ineffective (859)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which DEXLANSOPRAZOLE Alternatives Have Lower Nephrolithiasis Risk?
DEXLANSOPRAZOLE vs DEXMEDETOMIDINE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE
DEXLANSOPRAZOLE vs DEXPANTHENOL
DEXLANSOPRAZOLE vs DEXRAZOXANE